Glucose Health, Inc.
Data quality: 100%
GLUC
OTC
Manufacturing
Chemicals
$0.44
▲
$0.04
(10.75%)
Mkt Cap: 7.71 M
Price
$0.44
Mkt Cap
7.71 M
Day Range
$0.40 — $0.47
52-Week Range
$0.02 — $0.67
Volume
13,103
Open $0.47
50D / 200D Avg
$0.33
36.22% above
50D / 200D Avg
$0.18
149.58% above
Quick Summary
Key Takeaways
Negative free cash flow of -17,253.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)7232.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-96.52%
Op. Margin-36.82%
Safety
Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-0.29
Valuation
PE (TTM)
-90.68
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -90.7 | -1.5 |
| P/B | — | 1.6 |
| ROE % | — | -53.5 |
| Net Margin % | -96.5 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7232.14% | Revenue Growth (3Y) | 969.39% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 88,130.0 | Net Income (TTM) | -85,062.0 |
| ROE | N/A | ROA | -316.98% |
| Gross Margin | 65.39% | Operating Margin | -36.82% |
| Net Margin | -96.52% | Free Cash Flow (TTM) | -17,253.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.06 |
| Interest Coverage | -0.29 | Asset Turnover | 3.28 |
| Working Capital | -426,427 | Tangible Book Value | -426,232 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -90.68 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 87.52 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.22% | ||
| Market Cap | 7.71 M | Enterprise Value | 7.70 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0.01 |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 20.28% |
| SBC-Adj. FCF | -18,159 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | 313,229.0 | 4,272.0 | 2,739.0 | -224.0 | — |
| Net Income | -410,443.0 | -266,064.0 | -669,409.0 | -2.03 M | -568,650.0 |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 19,167.0 | 397.0 | -20,725.0 | -5,723.0 | -3,632.0 |
| Operating Income | -86,647.0 | -156,173.0 | -545,216.0 | -1.80 M | -532,479.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 48.0 | 48.0 | 4,000.0 | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 323,796.0 | 120,028.0 | 109,631.0 | 205,033.0 | 36,171.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Total Assets | 33,145.0 | 15,407.0 | 44,030.0 | 25,590.0 | 207,676.0 |
| Total Liabilities | 528,592.0 | 403,226.0 | 324,582.0 | 223,348.0 | 185,476.0 |
| Shareholders' Equity | -495,447.0 | -387,819.0 | -280,552.0 | -197,758.0 | 22,200.0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 20,542.0 | 2,055.0 | 711.0 | 1,076.0 | 82.0 |
| Current Assets | 32,905.0 | 15,107.0 | 43,730.0 | 25,590.0 | 1,076.0 |
| Current Liabilities | 528,592.0 | 403,226.0 | 324,582.0 | 223,348.0 | 185,476.0 |
{"event":"ticker_viewed","properties":{"ticker":"GLUC","listing_kind":"stock","pathname":"/stocks/gluc","exchange":"OTC","country":"US"}}